Retrospective analysis of tumor programmed death-ligand 1 expression in transbronchial biopsy samples

被引：0

作者：

Takahashi, Hirofumi ^{[1
]}

Shinagawa, Naofumi ^{[1
]}

Hatanaka, Yutaka ^{[2
]}

Kunisaki, Mamoru ^{[1
]}

Furuta, Megumi ^{[1
]}

Takashima, Yuuta ^{[1
]}

Shouji, Tetuaki ^{[1
]}

Kitai, Hidenori ^{[1
]}

Kikuchi, Hajime ^{[1
]}

Mizugaki, Hidenori ^{[1
]}

Asahina, Hajime ^{[1
]}

Kikuchi, Eiki ^{[1
]}

Kikuchi, Jyunko ^{[1
]}

Sakakibara, Jyun ^{[1
]}

Matsuno, Yoshihiro ^{[3
]}

Nishimura, Masaharu ^{[1
]}

机构：

[1] Hokkaido Univ, Sch Med, Dept Med 1, Sapporo, Hokkaido, Japan

[2] Hokkaido Univ Hosp, Res Div Genome Compan Diagnost, Sapporo, Hokkaido, Japan

[3] Hokkaido Univ Hosp, Dept Surg Pathol, Sapporo, Hokkaido, Japan

来源：

EUROPEAN RESPIRATORY JOURNAL | 2018年 / 52卷

关键词：

D O I：

10.1183/13993003.congress-2018.PA2806

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

PA2806

引用

页数：2

共 50 条

[31] Programmed Death-ligand 1 Expression in Upper Tract Urothelial Carcinoma
Skala, Stephanie L.
Liu, Tzu-Ying
Udager, Aaron M.
Weizer, Alon Z.
Montgomery, Jeffrey S.
Palapattu, Ganesh S.
Siddiqui, Javed
Cao, Xuhong
Fields, Kristina
Abugharib, Ahmed E.
Soliman, Moaaz
Hafez, Khaled S.
Miller, David
Lee, Cheryl T.
Alva, Ajjai
Chinnaiyan, Arul M.
Morgan, Todd M.
Spratt, Daniel E.
Jiang, Hui
Mehra, Rohit
EUROPEAN UROLOGY FOCUS, 2017, 3 (4-5): : 502 - 509
[32] Programmed death-ligand 1 expression in the immune compartment of colon carcinoma
Yilmaz, Osman
Pankaj, Amaya
Neyez, Azfar
Rickelt, Steffen
Taylor, Martin
Lang, Evan R.
Leijsen, Lieve
Dinaux, Anne
Shroff, Stuti G.
Crotty, Rory
Zhang, M. Lisa
Cerda, Sandra
Zhao, Qing
Ferrone, Cristina
Ting, David T.
Patil, Deepa T.
Yilmaz, Omer
Berger, David
Deshpande, Vikram
MODERN PATHOLOGY, 2022, 35 (11) : 1740 - 1748
[33] The expression of programmed death-ligand 1 in patients with invasive breast cancer
Meng, Yi
Wu, Hongyan
Yao, Yongzhong
Li, Rong
GLAND SURGERY, 2020, 9 (06) : 2106 - 2115
[34] Programmed death-ligand 1 expression in patients with primary or secondary myelofibrosis
Ibrahim, Moayed
Murphree, Catherine
Patel, Kirtesh
Mastrodomenico, Matthew
Saba, Nakhle S.
Safah, Hana
Schmid, Janet
Socola, Francisco
CANCER REPORTS, 2024, 7 (09)
[35] Programmed Death-Ligand 1 Expression and Response to the Anti-Programmed Death 1 Antibody Pembrolizumab in Melanoma
Daud, Adil I.
Wolchok, Jedd D.
Robert, Caroline
Hwu, Wen-Jen
Weber, Jeffrey S.
Ribas, Antoni
Hodi, F. Stephen
Joshua, Anthony M.
Kefford, Richard
Hersey, Peter
Joseph, Richard
Gangadhar, Tara C.
Dronca, Roxana
Patnaik, Amita
Zarour, Hassane
Roach, Charlotte
Toland, Grant
Lunceford, Jared K.
Li, Xiaoyun Nicole
Emancipator, Kenneth
Dolled-Filhart, Marisa
Kang, S. Peter
Ebbinghaus, Scot
Hamid, Omid
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (34) : 4102 - +
[36] Expression of Programmed Death-Ligand 1 and Programmed Death-1 in Patients with Extramammary Paget's Disease
Goto, Hiroyuki
Sugita, Kazunari
Yamamoto, Osamu
INDIAN JOURNAL OF DERMATOLOGY, 2021, 66 (02) : 169 - 173
[37] Role of Programmed Death-Ligand 1 in Cancer
Link, Tina
Dilip, Megha
Caruso, Olivia
Chang, Margaret
Kona, Abhinav
Liu, Jesse
Nathan, Ajay
Singh, Anita
Thomas-Wilkinson, Shiloh
FASEB JOURNAL, 2019, 33
[38] PROGRAMMED DEATH-LIGAND 1 (PD-L1) EXPRESSION IN PHEOCHROMOCYTOMA
Hashimoto, Yasuhiro
Imai, Atsushi
Hatakeyama, Shingo
Yoneyama, Takahiro
Koie, Takuya
Ohyama, Chikara
JOURNAL OF UROLOGY, 2017, 197 (04): : E474 - E474
[39] Tumor necroptosis is correlated with a favorable immune cell signature and programmed death-ligand 1 expression in cholangiocarcinoma
Thanpisit Lomphithak
Perawatt Akara-amornthum
Keigo Murakami
Masatoshi Hashimoto
Hajime Usubuchi
Erina Iwabuchi
Michiaki Unno
Zhenyu Cai
Hironobu Sasano
Siriporn Jitkaew
Scientific Reports, 11
[40] Assessment of programmed death-ligand 1 (PD-L1) expression in different breast tumor subtypes
Sobral-Leite, M.
de Vijver, K. Van
Kersten, K.
Peters, D.
Kok, M.
Broeks, A.
De Visser, K. E.
Schmidt, M. K.
EUROPEAN JOURNAL OF CANCER, 2016, 57 : S128 - S128

← 1 2 3 4 5 →